
Publications
Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
Nature communications
(2019)
10
225
(doi: 10.1038/s41467-018-07699-5)
Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease
(2019)
729392
(doi: 10.1101/729392)
Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery
J Neurosci Methods
(2018)
306
57
O2‐02‐02: TARGETING AMYLOID FORMATION USING RATIONALLY DESIGNED ANTIBODIES
Alzheimer's & Dementia
(2018)
14
p611
(doi: 10.1016/j.jalz.2018.06.2646)
Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine
ACS Chemical Biology
(2018)
13
2308
(doi: 10.1021/acschembio.8b00466)
Regional differences in dopamine release in the R6/2 mouse caudate putamen.
Electroanalysis
(2018)
30
1066
(doi: 10.1002/elan.201700827)
Systematic Development of Small Molecules to Inhibit Specific Microscopic Steps of Amyloid-Beta42 Aggregation in Alzheimer's Disease
Biophysical Journal
(2018)
114
225A
(doi: 10.1016/j.bpj.2017.11.1253)
Modulating Amyloid-Beta Aggregation to Reduce the Toxicity of its Oligomeric Aggregates
Biophysical Journal
(2018)
114
430A
(doi: 10.1016/j.bpj.2017.11.2382)
A natural product inhibits the initiation of α-synuclein aggregation & suppresses its toxicity
Proceedings of the National Academy of Sciences of the United States of America
(2017)
114
E1009
(doi: 10.1073/pnas.1610586114)
Attenuating the Toxicity of Amyloid-Beta Aggregation with Specific Species
Biophysical Journal
(2017)
112
494a
(doi: 10.1016/j.bpj.2016.11.2673)
- Page 1